Achilles Therapeutics plc

NASDAQ:ACHL

1.045 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 0000000000000000.580000.1800
Kosten van de omzet 1.1781.1791.1581.1971.30400.8370.8920.8921.0470.8380.8960.798000.290000.090.0450.045
Brutowinst -1.178-1.179-1.158-1.197-1.3040-0.837-0.892-0.892-1.047-0.838-0.896-0.798000.290000.09-0.045-0.045
Brutowinstmarge 0000000000000000.50000.500
Onderzoek- en ontwikkelingskosten 13.6510.13416.0314.71213.77413.86818.87610.59714.77613.01411.80710.69710.8448.8768.9615.2914.5473.832.7461.2322.5472.547
Algemene en administratieve kosten 4.1644.1593.6224.3844.3184.6853.9585.4375.775.9556.6535.0415.4454.8323.9583.0092.3951.7361.6891.0111.0021.002
Verkoop- en marketingkosten -1.174-1.182-1.1260000000000000000000
Verkoop-, algemene en administratieve kosten 2.992.9772.4964.3844.3184.6853.9585.4375.775.9556.6535.0415.4454.8323.9583.0092.3951.7361.6891.0111.0021.002
Overige kosten 1.4272.0021.3892.3891.2121.091-1.1813.5993.2711.6290.2262.8060.146-0.0450.0020.090.0870.352-16.731-6.941-6.941-6.941
Bedrijfskosten 16.64113.11218.52619.09618.09218.55322.83416.03420.54618.96918.4615.73816.28913.70812.9198.36.9425.5664.5582.4383.4973.497
Bedrijfsresultaat -17.819-14.291-19.684-19.096-18.092-18.553-22.834-16.034-20.546-18.969-18.46-15.738-16.289-13.708-12.919-8.3-6.942-5.566-4.435-2.243-3.549-3.549
Bedrijfsresultaat ratio 000000000000000-14.31000-12.46100
Totaal overige inkomsten en kosten netto 1.4292.0011.4012.3891.2121.091-1.1813.5993.2711.6290.2262.8060.146-0.0450.0020.090.0870.352-0.123-0.1050.0070.007
Inkomen voor belasting -16.39-12.29-18.283-16.707-16.88-17.462-24.015-12.435-17.275-17.34-18.234-12.932-16.143-13.753-12.917-8.21-6.855-5.214-4.558-2.348-3.542-3.542
Inkomen voor belasting ratio 000000000000000-14.155000-13.04400
Belastingkosten 0.008-0.0230.509-0.024-0.0340.0440.0410.0410.0140.015-0.0040.0160.0130.0120.0030.0010.0010.0010.001000
Nettowinst -16.398-12.267-18.792-16.683-16.846-17.506-24.056-12.476-17.289-17.355-18.23-12.948-16.156-13.765-12.92-8.21-6.855-5.214-4.558-2.348-3.542-3.542
Nettowinstmarge 000000000000000-14.155000-13.04400
WPA (Winst Per Aandeel) -0.41-0.3-0.47-0.42-0.42-0.44-0.61-0.32-0.44-0.45-0.64-0.34-0.45-8.38-0.32-5-4.17-3.18-6.3-3.66-5.89-5.89
Verwaterde WPA -0.41-0.3-0.47-0.42-0.42-0.44-0.61-0.32-0.44-0.45-0.64-0.34-0.45-8.38-0.32-5-4.17-3.18-6.29-3.66-5.89-5.89
EBITDA -16.641-13.112-18.526-19.096-18.092-18.553-22.834-16.034-19.63-17.916-17.623-14.906-15.459-12.919-12.52-8.3-6.942-5.469-4.336-2.162-3.488-3.488
EBITDA ratio 000000000000000-14.31000-12.01100